Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1085015]Researchers: Prof Mark Dawson (Principal investigator)
Brief description Mutations in epigenetic regulators in AML not only imply a causative role for these proteins in AML but also provide potential targets for therapeutic intervention. One of the most promising epigenetic therapies to have emerged in the last decade are small molecule inhibitors targeted to the Bromodomain and Extra Terminal (BET) family of proteins. This proposal will elucidate the cellular and molecular mechanisms that drive resistance to this new class of drugs
Funding Amount $AUD 764,796.85
Funding Scheme Project Grants
Notes Standard Project Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1085015
- nhmrc : 1085015